Distinguish polypoidal choroidal vasculopathy through choroidal alterations: A systematic review, meta‐analysis and narrative synthesis

PURPOSE: Polypoidal choroidal vasculopathy (PCV) is a vision-threatening choroidal vascular abnormality historically categorized as a subtype of neovascular age-related macular degeneration (nAMD). Accumulating evidence suggests that PCV may instead belong to the pachychoroid spectrum diseases, although its choroidal characteristics remain incompletely characterized and inconsistently reported. METHODS: PubMed, Embase and Ovid were searched for studies comparing choroidal structural and vascular parameters of PCV with healthy controls (HC), fellow eyes, nAMD or pachychoroid spectrum diseases. Outcomes supported by three or more studies were synthesized using quantitative meta-analysis, whereas outcomes supported by fewer than three studies were summarized using narrative synthesis and exploratory meta-analysis. RESULTS: Forty studies were included in the final analysis. Meta-analysis revealed that subfoveal choroidal thickness (SFCT) was significantly greater in PCV eyes than in HC, nAMD, and fellow eyes, but lower than central serous chorioretinopathy and pachychoroid neovasculopathy (PNV) eyes (all p < 0.05). PCV eyes also had lower choroidal vascularity index within the standard subfoveal width of 1.5 mm and higher choroidal vascular density (CVD) within the r = 10 mm FOV than HC eyes (p < 0.05). Narrative synthesis and exploratory meta-analysis suggested that PCV eyes may have greater total choroidal thickness than HC and nAMD eyes, as well as a higher ratio of Haller layer thickness to SFCT and larger choroidal luminal area than nAMD eyes at specific locations or areas. Besides, thick-choroid PCV demonstrated higher CVD in 200° ultra-wide ICGA images than nAMD, while the thin-choroid subtype exhibited lower CVD than PNV. CONCLUSIONS: PCV is characterized by a thicker and more vascular choroid than nAMD and HC, but a thinner and less vascular choroid than CSC and PNV. These findings, supported by both primary and exploratory meta-analyses, provide insights into PCV pathogenesis and its distinction from nAMD and other pachychoroid spectrum disorders.

Authors

Institutions

Publication Details

Journal
Acta Ophthalmologica
Published
2026-07-01
DOI
https://doi.org/10.1111/aos.70190
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distinguish polypoidal choroidal vasculopathy through choroidal alterations: A systematic review, meta‐analysis and narrative synthesis

Youxin Chen, Shiyu Cheng, Xingwang Gu, Xinyu Zhao et al.
Acta Ophthalmologica
Retinal Diseases and Treatments
article

Distinguish polypoidal choroidal vasculopathy through choroidal alterations: A systematic review, meta‐analysis and narrative synthesis

Youxin Chen, Shiyu Cheng, Xingwang Gu, Xinyu Zhao, Linxin Wei, Zhixuan Xie, Qing Zhao
article en

Abstract

PURPOSE: Polypoidal choroidal vasculopathy (PCV) is a vision-threatening choroidal vascular abnormality historically categorized as a subtype of neovascular age-related macular degeneration (nAMD). Accumulating evidence suggests that PCV may instead belong to the pachychoroid spectrum diseases, although its choroidal characteristics remain incompletely characterized and inconsistently reported. METHODS: PubMed, Embase and Ovid were searched for studies comparing choroidal structural and vascular parameters of PCV with healthy controls (HC), fellow eyes, nAMD or pachychoroid spectrum diseases. Outcomes supported by three or more studies were synthesized using quantitative meta-analysis, whereas outcomes supported by fewer than three studies were summarized using narrative synthesis and exploratory meta-analysis. RESULTS: Forty studies were included in the final analysis. Meta-analysis revealed that subfoveal choroidal thickness (SFCT) was significantly greater in PCV eyes than in HC, nAMD, and fellow eyes, but lower than central serous chorioretinopathy and pachychoroid neovasculopathy (PNV) eyes (all p < 0.05). PCV eyes also had lower choroidal vascularity index within the standard subfoveal width of 1.5 mm and higher choroidal vascular density (CVD) within the r = 10 mm FOV than HC eyes (p < 0.05). Narrative synthesis and exploratory meta-analysis suggested that PCV eyes may have greater total choroidal thickness than HC and nAMD eyes, as well as a higher ratio of Haller layer thickness to SFCT and larger choroidal luminal area than nAMD eyes at specific locations or areas. Besides, thick-choroid PCV demonstrated higher CVD in 200° ultra-wide ICGA images than nAMD, while the thin-choroid subtype exhibited lower CVD than PNV. CONCLUSIONS: PCV is characterized by a thicker and more vascular choroid than nAMD and HC, but a thinner and less vascular choroid than CSC and PNV. These findings, supported by both primary and exploratory meta-analyses, provide insights into PCV pathogenesis and its distinction from nAMD and other pachychoroid spectrum disorders.

Acta Ophthalmologica
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Medical Products Administration (CN), Peking Union Medical College Hospital (CN)
Good health and well-being
Openalex Percentile: Top 6%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.